View in EDS

Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents.

Saved in:
Bibliographic Details
Title: Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents.
Authors: Shaw HE; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas (H.E.S., D.R.P., B.M.G., L.R.F., W.E.F.); Drug Enforcement Administration, United States Department of Justice, Washington, DC (T.M.C.); and Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (C.R.J.)., Patel DR; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas (H.E.S., D.R.P., B.M.G., L.R.F., W.E.F.); Drug Enforcement Administration, United States Department of Justice, Washington, DC (T.M.C.); and Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (C.R.J.)., Gannon BM; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas (H.E.S., D.R.P., B.M.G., L.R.F., W.E.F.); Drug Enforcement Administration, United States Department of Justice, Washington, DC (T.M.C.); and Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (C.R.J.)., Fitzgerald LR; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas (H.E.S., D.R.P., B.M.G., L.R.F., W.E.F.); Drug Enforcement Administration, United States Department of Justice, Washington, DC (T.M.C.); and Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (C.R.J.)., Carbonaro TM; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas (H.E.S., D.R.P., B.M.G., L.R.F., W.E.F.); Drug Enforcement Administration, United States Department of Justice, Washington, DC (T.M.C.); and Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (C.R.J.)., Johnson CR; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas (H.E.S., D.R.P., B.M.G., L.R.F., W.E.F.); Drug Enforcement Administration, United States Department of Justice, Washington, DC (T.M.C.); and Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (C.R.J.)., Fantegrossi WE; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas (H.E.S., D.R.P., B.M.G., L.R.F., W.E.F.); Drug Enforcement Administration, United States Department of Justice, Washington, DC (T.M.C.); and Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (C.R.J.) WEFantegrossi@uams.edu.
Source: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2024 Jun 21; Vol. 390 (1), pp. 14-28. Date of Electronic Publication: 2024 Jun 21.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38272671
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shaw+HE%22">Shaw HE</searchLink>; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas (H.E.S., D.R.P., B.M.G., L.R.F., W.E.F.); Drug Enforcement Administration, United States Department of Justice, Washington, DC (T.M.C.); and Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (C.R.J.).<br /><searchLink fieldCode="AU" term="%22Patel+DR%22">Patel DR</searchLink>; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas (H.E.S., D.R.P., B.M.G., L.R.F., W.E.F.); Drug Enforcement Administration, United States Department of Justice, Washington, DC (T.M.C.); and Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (C.R.J.).<br /><searchLink fieldCode="AU" term="%22Gannon+BM%22">Gannon BM</searchLink>; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas (H.E.S., D.R.P., B.M.G., L.R.F., W.E.F.); Drug Enforcement Administration, United States Department of Justice, Washington, DC (T.M.C.); and Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (C.R.J.).<br /><searchLink fieldCode="AU" term="%22Fitzgerald+LR%22">Fitzgerald LR</searchLink>; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas (H.E.S., D.R.P., B.M.G., L.R.F., W.E.F.); Drug Enforcement Administration, United States Department of Justice, Washington, DC (T.M.C.); and Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (C.R.J.).<br /><searchLink fieldCode="AU" term="%22Carbonaro+TM%22">Carbonaro TM</searchLink>; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas (H.E.S., D.R.P., B.M.G., L.R.F., W.E.F.); Drug Enforcement Administration, United States Department of Justice, Washington, DC (T.M.C.); and Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (C.R.J.).<br /><searchLink fieldCode="AU" term="%22Johnson+CR%22">Johnson CR</searchLink>; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas (H.E.S., D.R.P., B.M.G., L.R.F., W.E.F.); Drug Enforcement Administration, United States Department of Justice, Washington, DC (T.M.C.); and Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (C.R.J.).<br /><searchLink fieldCode="AU" term="%22Fantegrossi+WE%22">Fantegrossi WE</searchLink>; Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas (H.E.S., D.R.P., B.M.G., L.R.F., W.E.F.); Drug Enforcement Administration, United States Department of Justice, Washington, DC (T.M.C.); and Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland (C.R.J.) WEFantegrossi@uams.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220376362%22">The Journal of pharmacology and experimental therapeutics</searchLink> [J Pharmacol Exp Ther] 2024 Jun 21; Vol. 390 (1), pp. 14-28. <i>Date of Electronic Publication: </i>2024 Jun 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0376362 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1521-0103 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200223565%22">00223565 </searchLink><i>NLM ISO Abbreviation: </i>J Pharmacol Exp Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38272671
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1124/jpet.123.001942
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 14
    Titles:
      – TitleFull: Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shaw HE
      – PersonEntity:
          Name:
            NameFull: Patel DR
      – PersonEntity:
          Name:
            NameFull: Gannon BM
      – PersonEntity:
          Name:
            NameFull: Fitzgerald LR
      – PersonEntity:
          Name:
            NameFull: Carbonaro TM
      – PersonEntity:
          Name:
            NameFull: Johnson CR
      – PersonEntity:
          Name:
            NameFull: Fantegrossi WE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 06
              Text: 2024 Jun 21
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1521-0103
          Numbering:
            – Type: volume
              Value: 390
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: The Journal of pharmacology and experimental therapeutics
              Type: main
ResultId 1